News coverage about Cooper Companies (NYSE:COO) has been trending somewhat positive this week, according to AlphaOne Sentiment. AlphaOne, a unit of Accern, identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cooper Companies earned a daily sentiment score of 0.18 on AlphaOne’s scale. AlphaOne also gave news articles about the medical device company an impact score of 20 out of 100, indicating that recent media coverage is very unlikely to have an effect on the company’s share price in the immediate future.
A number of research firms have issued reports on COO. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $220.00 price objective on shares of Cooper Companies in a report on Thursday, April 6th. Zacks Investment Research downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday, March 6th. Oppenheimer Holdings Inc. set a $203.00 price target on shares of Cooper Companies and gave the stock a “hold” rating in a report on Saturday, March 4th. Jefferies Group LLC boosted their price target on shares of Cooper Companies from $210.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, March 3rd. Finally, BMO Capital Markets reissued a “buy” rating on shares of Cooper Companies in a report on Friday, March 3rd. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Cooper Companies presently has an average rating of “Buy” and an average target price of $211.13.
Shares of Cooper Companies (NYSE:COO) traded down 0.18% during midday trading on Friday, hitting $200.13. The stock had a trading volume of 91,174 shares. The firm has a market cap of $9.79 billion, a price-to-earnings ratio of 32.98 and a beta of 0.56. The stock’s 50 day moving average price is $197.03 and its 200 day moving average price is $183.75. Cooper Companies has a 12 month low of $152.09 and a 12 month high of $202.70.
Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, March 2nd. The medical device company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.06. Cooper Companies had a return on equity of 15.38% and a net margin of 13.93%. The business earned $499.10 million during the quarter, compared to analysts’ expectations of $501.59 million. During the same quarter in the prior year, the firm earned $1.83 earnings per share. The business’s revenue was up 11.0% compared to the same quarter last year. On average, equities analysts forecast that Cooper Companies will post $9.25 EPS for the current fiscal year.
In related news, CEO Paul L. Remmell sold 3,605 shares of the stock in a transaction that occurred on Tuesday, April 4th. The stock was sold at an average price of $199.99, for a total value of $720,963.95. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jody S. Lindell sold 5,000 shares of the stock in a transaction that occurred on Tuesday, March 14th. The shares were sold at an average price of $193.38, for a total value of $966,900.00. The disclosure for this sale can be found here. Insiders have sold 22,698 shares of company stock valued at $4,461,175 in the last three months. Insiders own 1.60% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Somewhat Favorable News Coverage Very Unlikely to Affect Cooper Companies (COO) Share Price” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another site, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2017/04/21/cooper-companies-coo-receives-daily-news-impact-rating-of-0-18-updated.html.
Cooper Companies Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.